Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesInfectious and Parasitic Diseases, Systemic or Unspecified SitesDRG 866-viral-illness-without-mcc
    Ask Trek AI about this page

    Viral Illness without MCC: Inpatient Reimbursement Overview

    DRG 866 describes inpatient admissions for viral illness without Major Complication or Comorbidity and captures cases with limited resource use. This classification matters for inpatient reimbursement because it assigns payment levels based on lower expected resource consumption for uncomplicated viral admissions.

    Customize your policy alerts

    Sign up for drg 866 policy alerts

    Get alerted when payer policies referencing 866 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 866 Overview

    DRG 866 covers inpatient stays for patients admitted with viral illnesses that do not have any Major Complication or Comorbidity and that do not require significant additional resource use. Typical clinical presentations include uncomplicated viral respiratory infections, gastroenteritis of viral etiology, and other viral syndromes managed primarily with supportive care. This Diagnosis-Related Group matters for Medicare payment because it groups lower-resource viral admissions into a single payment classification, affecting hospital reimbursement and case-mix reporting. Understanding the clinical scope and payment classification helps hospitals anticipate payment implications for uncomplicated viral hospitalizations.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute antiviral and supportive care intervention trials: randomized or adaptive studies comparing timing, dosing, or delivery methods of antiviral agents and adjunctive supportive measures (for example, inhaled bronchodilators, supplemental oxygen strategies, or short-course corticosteroids as applicable) in hospitalized adults or children with confirmed viral respiratory illness without major complications. These trials focus on the initial inpatient encounter, enrolling patients early in hospitalization to measure time to clinical improvement, length of stay, need for escalation of care, and symptom resolution. Results inform clinicians on which acute interventions shorten hospitalization or prevent progression, and help payers evaluate which inpatient treatments provide value by reducing resource utilization within this DRG.
    • Comparative effectiveness and diagnostic stewardship studies: pragmatic trials or observational comparative studies assessing different diagnostic algorithms (rapid molecular testing panels, point-of-care antigen testing, or multiplex PCR) and their impact on antibiotic use, isolation practices, and length of stay among patients admitted with suspected viral illness but without major complications. These studies enroll broad inpatient populations across age groups to determine how testing strategies influence clinical decisions, antibiotic stewardship, and bed management. Findings are directly relevant to hospitals and payers because more accurate and timely diagnosis can reduce unnecessary antibiotic prescribing, decrease isolation days, and lower avoidable costs associated with prolonged stays in this DRG.
    • Post-discharge outcomes and readmission prevention research: cohort studies and randomized care-transition interventions testing enhanced discharge planning, outpatient follow-up models (telephone or telehealth monitoring), and education programs to reduce symptom relapse and 7- to 30-day readmissions for patients discharged after hospitalization for viral illness without major complications. These studies target patients with comorbidities (such as COPD, asthma, heart disease, or immunosuppression) who are at higher risk of early deterioration after discharge, measuring readmission rates, emergency visits, and patient-reported recovery. Results guide payers and providers in designing cost-effective post-discharge services that lower readmission risk and improve recovery metrics tied to reimbursement and quality reporting for this DRG.

    Related Codes

    853-INFECTIOUS-AND-PARASITIC-DISEASES-WITH-O-R-PROCEDURES-WITH-MCC

    Infectious and Parasitic Diseases with O.R. Procedures with MCC: Inpatient Reimbursement Overview

    854-INFECTIOUS-AND-PARASITIC-DISEASES-WITH-O-R-PROCEDURES-WITH-CC

    Infectious and Parasitic Diseases with O.R. Procedures with CC: Inpatient Reimbursement Overview

    855-INFECTIOUS-AND-PARASITIC-DISEASES-WITH-O-R-PROCEDURES-WITHOUT-CC-MCC

    Infectious and Parasitic Diseases with O.R. Procedures without CC/MCC: Inpatient Reimbursement Overview

    856-POSTOPERATIVE-OR-POST-TRAUMATIC-INFECTIONS-WITH-O-R-PROCEDURES-WITH-MCC

    Postoperative or Post-Traumatic Infections with O.R. Procedures with MCC: Inpatient Reimbursement Overview

    857-POSTOPERATIVE-OR-POST-TRAUMATIC-INFECTIONS-WITH-O-R-PROCEDURES-WITH-CC

    Postoperative or Post-Traumatic Infections with O.R. Procedures with CC: Inpatient Reimbursement Overview

    858-POSTOPERATIVE-OR-POST-TRAUMATIC-INFECTIONS-WITH-O-R-PROCEDURES-WITHOUT-CC-MCC

    Postoperative or Post-Traumatic Infections with O.R. Procedures without CC/MCC: Inpatient Reimbursement Overview

    862-POSTOPERATIVE-AND-POST-TRAUMATIC-INFECTIONS-WITH-MCC

    Postoperative and Post-Traumatic Infections with MCC: Inpatient Reimbursement Overview

    863-POSTOPERATIVE-AND-POST-TRAUMATIC-INFECTIONS-WITHOUT-MCC

    Postoperative and Post-Traumatic Infections without MCC: Inpatient Reimbursement Overview

    864-FEVER-AND-INFLAMMATORY-CONDITIONS

    Fever and Inflammatory Conditions: Inpatient Reimbursement Overview

    865-VIRAL-ILLNESS-WITH-MCC

    Viral Illness with MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 16

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.